Today, the SVP, Corp. Accounts of GenMark (GNMK), Michael Gleeson, sold shares of GNMK for $1,852.
In addition to Michael Gleeson, 4 other GNMK executives reported Sell trades in the last month.
See today’s analyst top recommended stocks >>
Based on GenMark’s latest earnings report for the quarter ending September 30, the company posted quarterly revenue of $15.8 million and GAAP net loss of $10.99 million. In comparison, last year the company earned revenue of $11.6 million and had a GAAP net loss of $15.41 million. Currently, GenMark has an average volume of 1.31M.
The insider sentiment on GenMark has been negative according to 101 insider trades in the past three months. This sentiment is lower than the average sentiment of company insiders in this sector.
Company insider trades’ information is brought to you by the DailyInsider, a proprietary algorithm that analyzes insider trading activity to detect the most attractive trading opportunities. To subscribe to the DailyInsider visit this page.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
GenMark Diagnostics, Inc. is a molecular diagnostics company, which engages in the development and commercialization of proprietary eSensor electrochemical detection technology. It also manufactures, sells, and supports instruments and molecular tests. The company was founded by Jon Faiz Kayyem on February 12, 2010 and is headquartered in Carlsbad, CA.
